Controlled Cycling and Quiescence Enables Efficient HDR in Engraftment-Enriched Adult Hematopoietic Stem and Progenitor Cells-Reference-Cited by-同舟云学术

Controlled Cycling and Quiescence Enables Efficient HDR in Engraftment-Enriched Adult Hematopoietic Stem and Progenitor Cells

Published:2020-09 Issue:9 Volume:32 Page:108093
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Shin Jiyung J.,Schröder Markus S.,Caiado Francisco^ORCID,Wyman Stacia K.,Bray Nicolas L.,Bordi Matteo,Dewitt Mark A.,Vu Jonathan T.^ORCID,Kim Won-Tae,Hockemeyer Dirk^ORCID,Manz Markus G.^ORCID,Corn Jacob E.^ORCID

Funder

Bill and Melinda Gates Foundation

California Institute of Regenerative Medicine

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

National Heart, Lung, and Blood Institute

Heritage Medical Research Institute

NOMIS Stiftung

Li Ka Shing Foundation

National Institute on Aging

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference92 articles.

1. Evidence that hematopoiesis may be a stochastic process in vivo;Abkowitz;Nat. Med.,1996

2. Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN;Arnoult;Nature,2017

3. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level;Bauer;Science,2013

4. Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle;Beerman;Cell Stem Cell,2014

5. Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential;Benveniste;Cell Stem Cell,2010

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From rest to repair: Safeguarding genomic integrity in quiescent cells;DNA Repair;2024-10

2. Correction of exon 2, exon 2–9 and exons 8–9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system;Scientific Reports;2024-09-11

3. DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome;Molecular Therapy - Methods & Clinical Development;2024-09

4. Enhancement of erythropoietic output by Cas9-mediated insertion of a natural variant in haematopoietic stem and progenitor cells;Nature Biomedical Engineering;2024-06-17

5. Non-viral DNA delivery and TALEN editing correct the sickle cell mutation in hematopoietic stem cells;Nature Communications;2024-06-11